SCIEJCR Q3
1-3
2026
影响因子区间
—
平台估算
投稿周期
ⓘ
22%
2025
中国作者发文占比
—
费用说明
ⓘ
收费
期刊简介:Therapeutic Advances in Chronic Disease publishes the highest quality peer-reviewed research, reviews and scholarly comment in the drug treatment of all chronic diseases. The journal has a strong clinical and pharmacological focus and is aimed at clinicians and researchers involved in the medical treatment of chronic disease, providing a forum in print and online for publishing the highest quality articles in this area.
【译文】Therapeutic Advances in Chronic Disease 发表最高质量的同行评审研究、评论和学术评论,专注于所有慢性疾病的药物治疗。该期刊具有强烈的临床和药理学重点,面向参与慢性疾病医疗治疗的临床医生和研究人员,为发表该领域最高质量的文章提供了一个印刷和在线平台。
出版社
SAGE Publishing
语言
English
学科
医学
ISSN
2040-6223
eISSN
2040-6231
出版频率
年刊
创刊年份
2004
投稿网址
https://uk.sagepub.com/en-gb/asi/journal/therapeutic-advances-chronic-disease#submission-guidelines
最近更新
2026-04-02 18:16:40

| 指标 | 当前值 | 近三年趋势 |
|---|---|---|
| JCR分区 | Q3 | 暂无 |
| 影响因子区间 | 1-3 | 暂无 |